Jain PharmaBiotech, Feb 2012, Pages: 264
of cardiovasculardrug delivery
Overview of cardiovasculardisease
Coronary artery disease
Angina pectoris
Limitations of current therapies for myocardial ischemic disease
Cardiomyopathies
Cardiac arrhythmias
Greystone Associates, Jan 2012
.
HIGHLIGHTS
· Analyzes and evaluates inhaled drugscurrently in development and assesses the market potential for existing and probable future products
· Examines inhalation device technology for commercial
Greystone Associates, May 2010
in pulmonary delivery of systemic drug therapies is focused on chronic diseases and refractory conditions – aliments that require frequent drug administration for a protracted period of time. The role of device
Axis Research Mind, Feb 2011, Pages: 509
. EMBOLIC PROTECTION DEVICES (EPD) A. BALLOON OCCLUSION DEVICES B. CATHETER OCCLUSION DEVICES C. FILTER DEVICES C. A REVIEW ON CARDIAC DISEASESCARDIOVASCULARDISEASESCARDIOVASCULARDISEASE STATISTICS
Jain PharmaBiotech, Feb 2012, Pages: 276
This report describes the latest concepts of the role of nitric oxide (NO) in health and disease as a basis for therapeutics and development of new drugs. Major segments of the market for nitric
PharmaVision, July 2007, Pages: 109
“The ability to deliver therapeutics site specifically,safely and efficiently remains a major challenge for the treatment of cardiovasculardiseases. Additional drug delivery hurdles will need
Jain PharmaBiotech, Feb 2012, Pages: 772
for CNS gene therapy
Carbon nanotubes for CNS gene therapy
Nanotechnology-based devices and implants for CNS
Nanoparticle-based drug delivery to the inner ear
Nanobiotechnology in cardiovasculardrug
Axis Research Mind, Feb 2011, Pages: 359
. FILTER DEVICES
C. A REVIEW ON CARDIAC DISEASESCARDIOVASCULARDISEASESCARDIOVASCULARDISEASE STATISTICS
MORTALITY FROM MAJOR CARDIOVASCULARDISEASES: UNITED STATES
RHEUMATIC HEART DISEASE
RHEUMATIC
Axis Research Mind, Feb 2011, Pages: 550
OCCURRENCES OF CARDIOVASCULARDISEASES WITNESS IMPROVEMENTS
IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS
A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
1. CARDIAC
Axis Research Mind, Feb 2011, Pages: 332
RISK
B. ELECTROCARDIOGRAPHY DEVICES (ECG)
A. RESTING ECG
B. STRESS ECG OR EXERCISE ECG
C. A REVIEW ON CARDIAC DISEASESCARDIOVASCULARDISEASESCARDIOVASCULARDISEASE STATISTICS
MORTALITY FROM MAJOR
Global Industry Analysts, Inc., Feb 2011, Pages: 477
St. Jude Medical, Inc. (USA) 101
EP MedSystems (USA) 101
13. GLOBAL MARKET PERSPECTIVE 102
Table 11: World Recent Past, Current & Future Market Analysis
for CardiovascularDisease Diagnostics
Life Science Intelligence, Inc., Dec 2009, Pages: 1763
in cardiovascular surgery
- 1-Painless intradermal drug delivery, 2-GERD diagnostic device, 3-Non-invasive
continuous glucose monitoring
- Porcine-derived tissue devices for ligament, cartilage, bone, and soft
Life Science Intelligence, Inc., Jan 2011
transplants, and blood diseases
- A drug-eluting stent coated with bioabsorbable polymers
- Hand-held point-of-care and home-based testing devices that measure blood viscosity for patients taking Warfarin
Axis Research Mind, Feb 2011, Pages: 396
OCCURRENCES OF CARDIOVASCULARDISEASES WITNESS IMPROVEMENTS
IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS
A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
1. CARDIAC
Axis Research Mind, Feb 2011, Pages: 363
RATES FOR CORONARY STENTS TECHNOLOGY – ANTIBODY COATED C. INVESTMENT FOCUS III. GLOBAL CARDIAC MEDICAL DEVICES INDUSTRY OVERVIEW FREQUENT OCCURRENCES OF CARDIOVASCULARDISEASES WITNESS IMPROVEMENTS
Axis Research Mind, Feb 2011, Pages: 391
OF CARDIOVASCULARDISEASES WITNESS IMPROVEMENTS
IN MEDICAL DEVICES FOR CARDIOVASCULAR APPLICATIONS
AN ENCOURAGING JAB FOR TORPID PERIODS
A. A REVIEW ON CARDIAC MEDICAL DEVICE TYPES
1. CARDIAC RHYTHM MANAGEMENT
Jain PharmaBiotech, Feb 2012, Pages: 864
and metabolomics. Molecular diagnostics technologies are used for the discovery of biomarkers and new tests are also based on biomarker.
Currently the most important applications of biomarkers are in drug discovery
Decision Resources, Inc., Feb 2005, Pages: 89
The treatment of cardiovasculardisease (CVD) represents a large and sustainable market growth opportunity for cardiovasculardevice companies.
In 2003, the worldwide cardiovasculardevice
